ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc (MIRM)

39.48
0.04
(0.10%)
Closed July 15 4:00PM
39.48
0.00
( 0.00% )
Pre Market: 4:45AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
39.48
Bid
34.88
Ask
39.48
Volume
-
0.00 Day's Range 0.00
23.14 52 Week Range 40.37
Market Cap
Previous Close
39.48
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
684,917
Shares Outstanding
47,133,021
Dividend Yield
-
PE Ratio
-11.39
Earnings Per Share (EPS)
-3.47
Revenue
186.37M
Net Profit
-163.42M

About Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
1970
Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was $39.48. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of $ 23.14 to $ 40.37.

Mirum Pharmaceuticals currently has 47,133,021 shares outstanding. The market capitalization of Mirum Pharmaceuticals is $1.86 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -11.39.

MIRM Latest News

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on July 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified...

Approbation du LIVMARLI de Mirum Pharmaceuticals dans l'Union européenne pour les patients atteints de PFIC

La Commission européenne accorde une autorisation de mise sur le marché au LIVMARLI pour le traitement de la PFIC chez les patients âgés de trois mois et plus. L’approbation fait suite à l’avis...

LIVMARLI von Mirum Pharmaceuticals wird in der Europäischen Union für Patienten mit PFIC zugelassen

Die Europäische Kommission erteilt LIVMARLI die Marktzulassung für die Behandlung von PFIC bei Patienten ab einem Alter von drei Monaten. Die Zulassung erfolgt im Anschluss an ein positives...

Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC

European Commission grants LIVMARLI marketing authorization for treatment of PFIC in patients three months and older. Approval follows positive opinion from CHMP concluding LIVMARLI’s clinical...

Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX

Submission based on the positive Phase 3 RESTORE study Mirum holds orphan designation for chenodiol in CTX Potential to have first and only therapy indicated for CTX in the US Mirum...

Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies

- VANTAGE PBC interim analysis shows 3.8 point reduction from baseline and 2.3 point placebo-adjusted (p=0.0026) reduction in primary endpoint of pruritus - VISTAS PSC interim analysis exceeds...

Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will host an investor call on Monday, June 17 at 8:30 a.m. ET to share interim analysis results from the Volixibat VANTAGE Phase...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that on June 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.359.2720730694736.1340.3735.1172231038.22115889CS
45.9517.74530271433.5340.3728.5694226533.92193672CS
1215.1862.469135802524.340.3723.1468491729.64982782CS
2612.9348.700564971826.5540.3723.1459684428.28849172CS
5212.9248.644578313326.5640.3723.1460573628.84733244CS
15623.3144.00494437616.1840.3712.8240194625.63942547CS
26026.48203.6923076921340.376.512629148624.34246925CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CDTConduit Pharmaceuticals Inc
$ 0.4738
(97.42%)
19.18M
WNWMeiwu Technology Company Ltd
$ 1.24
(39.33%)
2.16M
SYRASyra Health Corporation
$ 1.75
(31.09%)
1
WINTWindtree Therapeutics Inc
$ 4.50
(21.62%)
5
TPCSTechPrecision Corporation
$ 4.36
(17.18%)
1
GRNQGreenpro Capital Corporation
$ 0.9353
(-20.74%)
79.52k
AMIXAutonomix Medical Inc
$ 1.145
(-17.03%)
408.33k
AREBAmerican Rebel Holdings Inc
$ 0.561
(-16.64%)
137.41k
CYNCYNGN Inc
$ 7.67
(-16.45%)
10.96k
MFImF International Ltd
$ 0.80
(-14.44%)
3.1k
CDTConduit Pharmaceuticals Inc
$ 0.461
(92.08%)
19.11M
KRKR36Kr Holdings Inc
$ 0.3093
(4.07%)
4.28M
SLNASelina Hospitality PLC
$ 0.0673
(7.51%)
2.36M
WNWMeiwu Technology Company Ltd
$ 1.23
(38.20%)
2.15M
MAXNMaxeon Solar Technologies Ltd
$ 0.2217
(-2.33%)
1.36M

Your Recent History

Delayed Upgrade Clock